Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 10/25 10:01:47 pm
22.44 USD   -2.31%
10/25 BOSTON SCIENTIF : To Participate In 25th Annual Credit Suisse Health..
10/24 BOSTON SCIENTIF : Announces Scheduled Presentations at Transcatheter..
10/17 BOSTON SCIENTIF : Launches Resolution 360™ Clip
News SummaryMost relevantAll newsSector news 

Boston Scientific Corporation : BSX, ABT, ZMH, and ETRM Under StockCall’s Microscope

share with twitter share with LinkedIn share with facebook
share via e-mail
05/02/2013 | 02:00pm CEST

StockCall.com Provides Stock Research on Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

New York City, New York -- (May 02, 2013)

The Supreme Court, last year, upheld the Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades. While the healthcare industry has generally supported ACA, some features of the act have faced criticism. One such feature is the 2.3% tax on gross U.S. sales of medical devices. Medical appliances & equipment makers say that the tax will lead to higher costs for them, hurting innovation. While the Senate voted in favor of repealing the 2.3% tax, it is unlikely that the tax will be repealed. Shares of medical appliances & equipment companies ended mostly lower on Wednesday, tracking losses in the broad market. Among the major movers were Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). StockCall has released full comprehensive research on BSX, ABT, ZMH, and ETRM and these free technical analyses can be downloaded by signing up at


Shares of Boston Scientific Corporation fluctuated between gains and losses on Wednesday before finishing the day flat at $7.49 on volume of 12.95 million. Shares of the company have traded sideways this week. However, year-to-date, the stock has had an excellent run, jumping more than 30.70% as compared to a gain of nearly 11% for the S&P 500. BSX?s shares are currently trading nearly 5.80% below their 52-week high. Free technical analysis on BSX available by signing up at


Shares of Abbott Laboratories edged lower in Wednesday?s trading session, however, the losses were limited. The stock ended the day 0.08% lower at $36.89 on volume of 5.46 million after trading between $36.62 and $37.20. Despite the pullback, Abbott?s shares are up nearly 1.20% for the week. The stock has gained more than 18.50% so far in 2013, outperforming the S&P 500. However, shares of ABT have been struggling to break through $37.50 resistance level. The stock is currently trading well above its 50-day and 200-day moving averages. Register today and access the free research on ABT at


Zimmer Holdings Inc.?s shares also slipped in trading on Wednesday, tracking losses in the broad market. The stock closed 1.50% lower at $75.30 on volume of 617,800. Despite the pullback, the company?s shares are currently trading close to their 52-week high of $77.53. Shares of ZMH have been facing resistance at around $76.50. The stock currently has strong support at around $73. Zimmer?s shares are currently trading well above their 50-day and 200-day moving averages which suggests that market sentiment is bullish on the stock. The positive trend is further confirmed by recent volume activity. The free report on ZMH can be downloaded by signing up now at


Shares of EnteroMedics Inc. tumbled in Wednesday?s trading session after the company reported its financial results for the first quarter. The stock closed 9.59% lower at $0.868 on above average volume of 601,300 after touching an intra-day low of $0.86. Shares of ETRM are currently trading close to their 52-week low of $0.81. Year-to-date, the stock has now fallen nearly 69%. Most of the losses came in mid-February when the stock saw a huge sell-off. EnteroMedics? shares have now slipped below their 50-day moving average. Free report on ETRM can be accessed by registering at


About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at


Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)

© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
10/25 BOSTON SCIENTIFIC : To Participate In 25th Annual Credit Suisse Healthcare Confe..
10/24 BOSTON SCIENTIFIC : Announces Scheduled Presentations at Transcatheter Cardiovas..
10/20 BOSTON SCIENTIFIC : Trademark Application for "AGENT" Filed
10/20 BOSTON SCIENTIFIC : Trademark Application for "AGILE" Filed by Boston Scientific
10/20 BOSTON SCIENTIFIC : New Mitotic Inhibitors Data Have Been Reported by Investigat..
10/20 BOSTON SCIENTIFIC : Professor Ian Meredith To Join Boston Scientific As Executiv..
10/19 MEDTRONIC : Federal Contracts Awarded by Federal Agencies in Iowa (Oct. 19)
10/19 BOSTON SCIENTIFIC : $31,890 Federal Contract Awarded to Boston Scientific
10/17 BOSTON SCIENTIFIC : Launches Resolution 360™ Clip
10/13 BOSTON SCIENTIFIC : Competition Seeks Concepts Applying Analytics to Big Data fo..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10/24DJPHILIPS : Profit Lifted by Health-Care Business
10/11 Wall Street stocks slide, dollar hits 8-month high
10/11DJStocks Slide on Disappointing Earnings
10/10DJILLUMINA : Gene-Sequencing Firm Illumina Cuts Revenue Guidance
09/06DJDanaher to Buy Diagnostics Company Cepheid for $4 Billion
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
10/25 Notable earnings before Wednesday?s open
10/20 SetPoint Leads The Crohn's Medtech Race By Being The Only Entrant
10/07 Warren Buffett's Trade
10/07 Boston Scientific commences $8-a-share tender offer for EndoChoice
09/27 Disney Prepping Twitter Bid
Financials ($)
Sales 2016 8 313 M
EBIT 2016 1 961 M
Net income 2016 703 M
Debt 2016 4 177 M
Yield 2016 -
P/E ratio 2016 44,88
P/E ratio 2017 23,47
EV / Sales 2016 4,18x
EV / Sales 2017 3,69x
Capitalization 30 535 M
More Financials
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 27,5 $
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHILIPS15.94%28 193
More Results